Cardiometabolic Health Congress

JULY 17, 2024

February 2024 FDA Approvals: Innovations in Cardiovascular Interventions XACT Carotid Stent System (Approved: 02/07/2024) This approval expands the indications to be used during a Transcarotid Artery Revascularization (TCAR) procedure to prevent future strokes. The label includes a “black box” warning for CV risk due to blood clots.

Tricuspid 59

Tricuspid Open-Heart Surgery Kidney Disease Pediatrics 59

Open Heart

JULY 10, 2023

The risk of AF was estimated using the FIND-AF (Future Innovations in Novel Detection of Atrial Fibrillation) risk score. We calculated cumulative incidence rates and fit Fine and Gray’s models at 1, 5 and 10 years for nine diseases and death adjusting for competing risks. to 5.22; 4.32), peripheral vascular disease (44.6;

Atrial Fibrillation 52

Atrial Fibrillation Myocardial Infarction Kidney Disease Innovation 52

Cardiometabolic Health Congress

AUGUST 14, 2024

This October, we gather for the largest and most innovative cardiometabolic event, honoring Dr. Bakris’ profound impact on our community. With his support, CMHC has championed a vision of a brighter future for clinicians, patients, and the entire healthcare sector.

CME 72

CME Education Diabetes Innovation 72

Cardiometabolic Health Congress

AUGUST 8, 2024

These interconnected diseases pose a significant global health threat, with cardiovascular diseases alone accounting for one-third of all deaths worldwide , according to the World Health Organization. We need a comprehensive and innovative approach to cardiorenal metabolic management and risk reduction to address this challenge.

Education 59

Education Cardiovascular Disease Diabetes Kidney Disease 59

GEMMS

MAY 22, 2024

In this article, we will explore the top 10 trends shaping the future of cardiovascular medicine, highlighting the innovative technologies and approaches that are revolutionizing the field. Genetic testing and DNA sequencing improve the accuracy of predicting heart disease risk.

Heart Disease 52

Heart Disease Blood Pressure Technology Innovation 52

Cardiometabolic Health Congress

OCTOBER 26, 2023

2023 conference, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) still list NASH and NAFLD as the official terms for conditions in which inflammation and fat cause damage to the liver. Nonalcoholic fatty liver disease (NAFLD) & NASH. As of the Oct. 78(1), pp. doi: 10.1097/hep.0000000000000412.

Diabetes 52

Diabetes Kidney Disease Obesity Anatomy 52

Cardiometabolic Health Congress

NOVEMBER 14, 2024

Attendees, including hundreds of health professionals, gained access to the latest knowledge and developments in the field, from exclusive insights from one of the foremost authorities on atherosclerosis, Dr. Peter Libby, to innovations like new therapeutic agents and exciting advancements in renal protection. In the U.S.,

CME 103

CME Obesity Heart Failure Biomarkers 103